Back to News
Market Impact: 0.2
Vitroscope Raises $7M to Scale Live-Tissue Platform
Source: Business Wire
Healthcare & BiotechPrivate Markets & VentureTechnology & Innovation
Vitroscope raised $7 million to scale its live-tissue platform: a $5 million seed round co-led by Cerberus Ventures and YZR Capital, plus $2 million from the Research Council of Norway.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell-Lumentum Deal Puts Optical Networking at the Center of the AI Boom
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- AI Inference Startup Fal Raises Capital at $16 Billion Valuation
- North Korean fake job interview led to $6.3B Binance heist
- AMD’s OpenAI, Meta chip deals trigger $1 billion quarterly charge